Corporate & Investor Presentation
Propeller has demonstrated compelling clinical outcomes
L
1 Impact of the Propeller solution tracking inhaler usage and location
SABA use over time
# per day
Symptom free days
%
2.0
1.5
-50%
1.0
+32%
75
50
Healthcare utilization
Events
-25%
79
0.5
25
45
Uncontrolled
COPD
0.0
T
0
Before
50
100
150
200
50
100
150
200
Uncontrolled
Asthma
Decrease in
medication usage
Adherence
%
36
36
+58%
57
40
Control
Intervention
Improvement in
adherence
50
© 2022 ResMed | Corporate & Investor Presentation - updated 28APR22
Improvement in QOL
59
After
Reduction in healthcare
utilization
QoL: Rescue Inhaler use per day
# times used
Acute care utilization
Events per 100 patient years
1.5
1.0
-75%
0.5
0.0
1
180
Improvement in QOL
13
Pre-enrollment
Post-enrollment
12
6
5
365
ED + Hosp. ED
2
0
Hosp.
Reduction in healthcare
utilization
ResMedView entire presentation